Skip to main content

June 2015

academics

 

Clinical research courses

The US FDA has granted approval to Cipla's Lopinavir, Ritonavir (LPV/r) 40mg/ 10 mg oral pellets for paediatric specific treatment of HIV in infants. Cipla was working for many years in collaboration with Diana Gibb, professor of epidemiology, senior programme leader and honorary consultant paediatrician at Medical Research Council Clinical Trials Unit at UCL (University College London) towards development of this novel child-friendly formulation which has been approved by US FDA under the President’s Emergency Plan for AIDS Relief (PEPFAR) programme. This product is a first step in making accessible more modern and appropriately formulated treatment available to the most vulnerable of HIV patients – young children.

The Indian Council on Medical Research (ICMR) and the National Institutes of Health (NIH), US, will soon begin collaborative research on ‘Prevention of Sexually Transmitted Diseases & HIV/AIDS’.  The joint research programme will also have thrust on HIV and AIDS-associated co-morbidities. Under this, the focus will be on utilsation of new/enhanced therapeutics for HIV-related co-morbidities such as HCV and their impact on disease outcomes; and enhanced targeted outreach strategies for HCV testing, prevention, and treatment/care engagement; integrated approaches for addressing the complex bio-behavioral factors associated with HCV/HIV. In this regard a joint Indo-US workshop is proposed to be held in September 2015 to encourage investigators for the Indo-US collaborative projects. Under translational research, the focus will be on studies to develop and test innovative HIV prevention strategies in young populations, particularly  adolescents; and also on studies to better understand linkages between reproductive health options and HIV infection in men and women.

A new research claims, the high level of zinc in the body may contribute to kidney stone formation. Zinc is key nutrient that is required for body. It may be the core by which stone formation starts, showed the results that might ultimately lead to the identification of new preventive and therapeutic approaches for urinary stone and diseases related to it. The study appeared in the scientific journal PLOS ONE.

HLL Lifecare (Govt. of India enterprise) invites Dy. Manager- QA/ QC/ Microbiology | 5 Posts

HLL Lifecare Limited is a Mini Ratna Company of Govt. of India under the Ministry of Health & Family Welfare. HLL, a Schedule-B Public Sector Enterprise is today a multi product, multi unit organization addressing various public health challenges. The Company with seven manufacturing units and marketing offices throughout the country is engaged in the manufacturing and marketing of a wide range of contraceptives and healthcare products. The company has also ventured into Infrastructure Development, Procurement & Consultancy Services, setting up of Life Spring Hospitals, Women's Health Pharma Division and setting up of Diagnostic Centres.

HLL offers a challenging work environment with ample opportunity for advancement, for personal and professional growth.

Post: Dy. Manager

Walk in interview for Pharmacist (Visiting Basis) in Mormugao Port, Goa

Mormugao Port, GOA one of the oldest ports on the west coast of India, with a fine natural harbour, has been relentlessly serving the nation in its economic development for over a century. The Port was declared a Major Port on 2.12.1963. Mormugao Port, GOA is the premier iron ore exporting Port of India with an annual throughput of around 50.02 million tonnes of traffic. Though ore is the predominant cargo, there has been a steady increase in liquid bulk and general cargo traffic ever since its joining the ranks of the Major Ports of India. Excellent facilities, high productivity, streamlined administration and a dedicated workforce all go towards making this Port one of the most efficient Port in the Indian subcontinent. With all these attributes, Mormugao Port, GOA has tremendous potential to cater to the needs of trade and industry and to contribute to the economic development of the Nation.

Post: Pharmacist (Visiting Basis)

Post doctoral Fellow in UM-DAE CBS

University of Mumbai-Department of Atomic Energy Centre for Excellence in Basic Sciences (UM-DAE CBS) has been established on the Kalina campus of the University of Mumbai to impart high quality education in the Basic Sciences after the 10+2 (or equivalent) level of schooling, in a vibrant academic ambiance by a faculty of distinguished teachers and scientists.

Post: Post-Doctoral Fellows

BioCision is a leading supplier of cell cryopreservation products, systems, and solutions announced that it will collaborate with Celgene Cellular Therapeutics (CCT) (a subsidiary of Celgene Corporation), for development of a cell thawing solution based on BioCision’s proprietary ThawSTAR technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease.

Mylan N.V., a global pharmaceutical company,  launched guanfacine extended-release tablets, 1 mg, 2 mg, 3 mg, and 4 mg, which is the generic version of Shire's Intuniv tablets in US markets. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications.The company received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product.